Interesting to note that of the 20 patients treated, 5 had EMD and of the 6 responses to treatment, 3 of them were EMD.
I view this presentation as highly encouraging, hopefully we can start treating healthier patients with RC220 sooner rather than later. RAC appears to have a product that works, that's more than half the battle won.
Best of luck and congratulations to Prof Nagler and the team at Sheba.
Interesting to note that of the 20 patients treated, 5 had EMD...
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.030(2.10%) |
Mkt cap ! $238.5M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.46 | $1.38 | $123.1K | 87.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19987 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 330 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |